Dergiler / Erciyes Medical Journal / 2019 / Cilt: 41 - Sayı: 3

Residual Kidney Function in Hemodialyzed Patients and Related Factors

Sayfa
327–332
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Additional studies that include RKF measurement at certain time intervals and long-term observation are needed.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Residual kidney function (RKF) is a strong marker of the remaining capacity of the kidneys in patients with end-stage renal disease (ESRD).
📊
Temel Bulgular & Veri:Materials and Methods: The study was performed at Kars State Hospital with 73 HD patients.
💡
Sonuç & Katkı:Additional studies that include RKF measurement at certain time intervals and long-term observation are needed.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Residual kidney function (RKF) is a strong marker of the remaining capacity of the kidneys in patients with end-stage renal disease (ESRD). The fact that RKF declines in the first year of hemodialysis (HD) has drawn more attention recently. The aim of this study was to determine and analyze the current RKF level and related factors in patients undergoing HD treatment. Materials and Methods: The study was performed at Kars State Hospital with 73 HD patients. Residual renal urea clearance (KRU) was measured to determine RKF. Patient urine volume was determined during the period between the end of the first HD session of the week and the beginning of the next HD session. The patients were classified into 3 groups according to KRU level: 2 mL/minute. The duration of HD treatment, biodemographic characteristics, biochemical and hormonal analyses, HD adequacy, ESRD etiology, and co-morbidities were compared between groups. A p value of less than 0.05 was considered statistically significant (confidence interval: 95%). Results: There was a statistically significant difference between the KRU value and the duration of HD treatment (p<0.001), ESRD etiology (p=0.037), serum potassium level (p=0.028), phosphorus level (p=0.036), urine volume (p<0.001), ultrafiltration (UF) volume (p=0.002), and body mass index (p=0.002). Patients with a urine volume of <100 mL/day had a longer duration of HD treatment of 6.9±4.2 years (p=0.021), as well as a greater quantity of UF administered 723±230 mL/hour (p<0.001). Conclusion: Rather than provide an explanation of a cause-effect relationship for RKF loss, the findings of this study may contribute to the monthly interpretation and regulation of HD therapy. Additional studies that include RKF measurement at certain time intervals and long-term observation are needed.

🔖

Bu Makaleye Atıf Yap

ERDOĞDU, H. İ., KARA, F. (2019). Residual Kidney Function in Hemodialyzed Patients and Related Factors. Erciyes Medical Journal, Cilt: 41 - Sayı: 3, 327–332. https://ajindex.com/articles/186317

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Hur I, Lee YK, Kalantar-Zadeh K, Obi Y. Individualized Hemodialysis Treatment: A Perspective on Residual Kidney Function and Precision Medicine in Nephrology. Cardiorenal Med 2019
  2. 9(2): 69–82. [CrossRef] Lowenstein J, Grantham JJ. Residual renal function: a paradigm shift. Kidney Int 2017
  3. 91(3): 561–5. [CrossRef] [No authors listed] Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996
  4. 7(2): 198–207. Krediet RT. Preservation of Residual Kidney Function and Urine Volume in Patients on Dialysis. Clin J Am Soc Nephrol 2017
  5. 12(3): 377–9. [CrossRef] Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, et al. Effect of frequent hemodialysis on residual kidney function. Kidney Int 2013
  6. 83(5): 949–58. [CrossRef] Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K. Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 2009
  7. 24(8): 2502–10. [CrossRef] Liu X, Dai C. Advances in Understanding and Management of Residual Renal Function in Patients with Chronic Kidney Disease. Kidney Dis (Basel) 2017
  8. 2(4): 187–96. [CrossRef] Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 2010
  9. 56(2): 348–58. [CrossRef] Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 2001
  10. 38(1): 85–90. [CrossRef] Mathew AT, Fishbane S, Obi Y, Kalantar-Zadeh K. Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int 2016
  11. 90(2): 262–71. [CrossRef] van der Wal WM, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT, Korevaar JC, et al. Full loss of residual renal function causes higher mortality in dialysis patients
  12. findings from a marginal structural model. Nephrol Dial Transplant 2011
  13. 26(9): 2978–83. [CrossRef] Kjaergaard KD, Jensen JD, Peters CD, Jespersen B. Preserving residual renal function in dialysis patients: an update on evidence to assist clinical decision making. NDT Plus 2011
  14. 4(4): 225–30. [CrossRef] National Kidney Foundation. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. A